Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Completed Phase 1 Interventional

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

ClinicalTrials.gov ID: NCT00890747

Public ClinicalTrials.gov record NCT00890747. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Oct 22, 2026, 3:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/Pharmacokinetic Study of Sunitinib in Patients With Cancer Who Also Have HIV and Are on HAART Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This phase I trial studies the side effects and the best dose of sunitinib malate in treating human immunodeficiency virus (HIV)-positive patients with cancer receiving antiretroviral therapy. Sunitinib malate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.

Study identification

NCT ID
NCT00890747
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Enrollment
42 participants

Conditions and interventions

Conditions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2009 (Type not available)
Primary completion
May 2011 (Actual)
Completion
Not listed
Last update posted
Mar 17, 2014

Started 2009

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
Jonsson Comprehensive Cancer Center Los Angeles California 90095 —
Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C. District of Columbia 20057 —
Northwestern University Chicago Illinois 60611 —
AIDS - Associated Malignancies Clinical Trials Consortium Rockville Maryland 20850 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Washington University - Jewish Saint Loius Missouri 63110 —
Memorial Sloan Kettering Cancer Center New York New York 10065 —
Albert Einstein College of Medicine The Bronx New York 10461 —
Case Western Reserve University Cleveland Ohio 44106 —
Abramson Cancer Center of The University of Pennsylvania Philadelphia Pennsylvania 19104 —
Virginia Mason Medical Center Seattle Washington 98101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00890747, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 17, 2014 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00890747 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →